x

Search for a clinical trial

* (*) mandatory field

A Phase 2b Extension Study of Ataluren (PTC124) in Subjects With Nonsense-Mutation-Mediated Duchenne and Becker Muscular Dystrophy (terminated)

  • Type of clinical trial : Drug clinical trial
  • Recruiting project : No
  • Status : Terminated trial
  • Funding body(ies) :
  • Geographic coverage : Global
  • Sponsor : Genzyme europe b.v., Ptc therapeutics, inc.
  • Website
    • Phase : II
  • Principal investigator of clinical trial

  • Dr Jaume COLOMER OFERIL
  • Servicio de Neurología
  • Hospital Sant Joan de Déu Barcelona
  • Paseo de Sant Joan de Déu, 2
  • 08950 ESPLUGUES DE LLOBREGAT
  • SPAIN
  • More information
  • Phone  : 34 93 253 21 00
  • Fax  : -
  • Website
Last update: May 2012

Additional information

The documents contained in this web site are presented for information purposes only. The material is in no way intended to replace professional medical care by a qualified specialist and should not be used as a basis for diagnosis or treatment.